Windlas Biotech Limited (BOM:543329)
1,035.20
+17.20 (1.69%)
At close: Oct 6, 2026
| Market Cap | 21.38B +8.5% |
| Revenue (ttm) | 9.42B +18.5% |
| Net Income | 664.44M +1.9% |
| EPS | 31.13 +1.2% |
| Shares Out | n/a |
| PE Ratio | 32.18 |
| Forward PE | n/a |
| Dividend | 6.30 (0.61%) |
| Ex-Dividend Date | Jul 16, 2026 |
| Volume | 3,322 |
| Open | 1,004.30 |
| Previous Close | 1,018.00 |
| Day's Range | 1,002.10 - 1,037.95 |
| 52-Week Range | 699.35 - 1,181.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 6, 2026 |